Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder

ClinicalTrials.gov ID: NCT02333071

Public ClinicalTrials.gov record NCT02333071. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 8:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Randomized, Double-blind, Placebo-controlled, Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Subcutaneously Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial with an optional Open-label Extension to evaluate the efficacy of bremelanotide (BMT), administered subcutaneously (SC) on an as needed basis for the treatment of HSDD (with or without decreased arousal) in premenopausal females.

Study identification

NCT ID
NCT02333071
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Palatin Technologies, Inc
Industry
Enrollment
723 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2014 (Type not available)
Primary completion
Jul 2016 (Actual)
Completion
Jun 30, 2017 (Actual)
Last update posted
Apr 9, 2021

2014 – 2017

United States locations

U.S. sites
87
U.S. states
38
U.S. cities
82
Facility City State ZIP Site status
Palatin Clinical Site 121 Birmingham Alabama 35211 —
Palatin Clinical Site 110 Huntsville Alabama 35801 —
Palatin Clinical Site 106 Mobile Alabama 36608 —
Palatin Clinical Site 149 Scottsdale Arizona 85251 —
Palatin Clinical Site 157 Tucson Arizona 85712 —
Palatin Clinical Site 166 Little Rock Arkansas 72205 —
Palatin Clinical Site 102 National City California 91950 —
Palatin Clinical Site 164 Oceanside California 92056 —
Palatin Clinical Site 152 Orange California 92868 —
Palatin Clinical Site 188 Sacramento California 95821 —
Palatin Clinical Site 141 San Diego California 92103 —
Palatin Clinical Site 187 Walnut Creek California 94598 —
Palatin Clinical Site 160 Centennial Colorado 80239 —
Palatin Clinical Site 185 Colorado Springs Colorado 80907 —
Palatin Clinical Site 130 Bradenton Florida 34208 —
Palatin Clinical Site 128 Hollywood Florida 33024 —
Palatin Clinical Site 134 Jacksonville Florida 32256 —
Palatin Clinical Site 108 Melbourne Florida 32934 —
Palatin Clinical Site 105 Orlando Florida 32801 —
Palatin Clinical Site 131 South Miami Florida 33143 —
Palatin Clinical Site 144 St. Petersburg Florida 33709 —
Palatin Clinical Site 101 West Palm Beach Florida 33401 —
Palatin Clinical Site 116 Decatur Georgia 30030 —
Palatin Clinical Site 142 Savannah Georgia 31406 —
Palatin Clinical Site 171 Meridian Idaho 83642 —
Palatin Clinical Site 179 Evansville Indiana 47710 —
Palatin Clinical Site 165 Lafayette Indiana 47905 —
Palatin Clinical Site 154 Mishawaka Indiana 46545 —
Palatin Clinical Site 184 West Des Moines Iowa 50266 —
Palatin Clinical Site 155 Overland Park Kansas 66202 —
Palatin Clinical Site 104 Wichita Kansas 67211 —
Palatin Clinical Site 191 Louisville Kentucky 40291 —
Palatin Clinical Site 194 Eunice Louisiana 70535 —
Palatin Clinical Site 186 New Orleans Louisiana 70119 —
Palatin Clinical Site 183 Bangor Maine 04401 —
Palatin Clinical Site 159 Annapolis Maryland 21401 —
Palatin Clinical Site 119 Boston Massachusetts 02131 —
Palatin Clinical Site 126 Watertown Massachusetts 02472 —
Palatin Clinical Site 163 Bingham Farms Michigan 48025 —
Palatin Clinical Site 181 Rochester Michigan 48307 —
Palatin Clinical Site 182 Olive Branch Mississippi 38654 —
Palatin Clinical Site 170 St Louis Missouri 63141 —
Palatin Clinical Site 180 Billings Montana 59102 —
Palatin Clinical Site 192 Norfolk Nebraska 68701 —
Palatin Clinical Site 168 Omaha Nebraska 68114 —
Palatin Clinical Site 111 Las Vegas Nevada 89106 —
Palatin Clinical Site 125 Las Vegas Nevada 89119 —
Palatin Clinical Site 109 Las Vegas Nevada 89128 —
Palatin Clinical Site 195 Las Vegas Nevada 89128 —
Palatin Clinical Site 120 Moorestown New Jersey 08057 —
Palatin Clinical Site 123 Plainsboro New Jersey 08536 —
Palatin Clinical Site 124 Albuquerque New Mexico 87106 —
Palatin Clinical Site 189 Johnson City New York 13790 —
Palatin Clinical Site 107 New York New York 10016 —
Palatin Clinical Site 158 Port Jefferson New York 11777 —
Palatin Clinical Site 127 Poughkeepsie New York 12601 —
Palatin Clinical Site 190 Rochester New York 14609 —
Palatin Clinical Site 137 Charlotte North Carolina 28209 —
Palatin Clinical Site 135 Winston-Salem North Carolina 27103 —
Palatin Clinical Site 156 Winston-Salem North Carolina 27103 —
Palatin Clinical Site 139 Fargo North Dakota 58103 —
Palatin Clinical Site 140 Akron Ohio 44311 —
Palatin Clinical Site 122 Beachwood Ohio 44122 —
Palatin Clinical Site 151 Cincinnati Ohio 45227 —
Palatin Clinical Site 112 Columbus Ohio 43213 —
Palatin Clinical Site 115 Englewood Ohio 45322 —
Palatin Clinical Site 132 Medford Oregon 97504 —
Palatin Clinical Site 146 Portland Oregon 97210 —
Palatin Clinical Site 169 Jenkintown Pennsylvania 19046 —
Palatin Clinical Site 172 Media Pennsylvania 19063 —
Palatin Clinical Site 117 Warwick Rhode Island 02886 —
Palatin Clinical Site 162 Anderson South Carolina 29621 —
Palatin Clinical Site 143 Bluffton South Carolina 29910 —
Palatin Clinical Site 114 Mt. Pleasant South Carolina 29464 —
Palatin Clinical Site 145 Mt. Pleasant South Carolina 29464 —
Palatin Clinical Site 161 Memphis Tennessee 38119 —
Palatin Clinical Site 129 Nashville Tennessee 37203 —
Palatin Clinical Site 174 Bryan Texas 77802 —
Palatin Clinical Site 113 Dallas Texas 75231 —
Palatin Clinical Site 118 San Antonio Texas 78229 —
Palatin Clinical Site 176 Sugar Land Texas 77479 —
Palatin Clinical Site 100 Murray Utah 84123 —
Palatin Clinical Site 103 Charlottesville Virginia 22903 —
Palatin Clinical Site 138 Virginia Beach Virginia 23456 —
Palatin Clinical Site 133 Spokane Washington 99207 —
Palatin Clinical Site 150 Tacoma Washington 98405 —
Palatin Clinical Site 193 Middleton Wisconsin 53562 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02333071, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 9, 2021 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02333071 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →